• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢甲肟在胸腔积液中的渗透情况]

[Penetration of cefmenoxime into pleural fluid].

作者信息

Miyazaki N, Kajiki A, Yamazaki H, Harada S, Kido M, Kuroiwa A

出版信息

Jpn J Antibiot. 1984 Oct;37(10):1763-5.

PMID:6094856
Abstract

Single doses of cefmenoxime (CMX), 1 g intravenous drip infusion, were administrated to 5 patients with pleural effusion. The study group consisted of 3 men and 2 women, aged 38 to 69 years (mean 54.8 years); 4 had carcinoma with pleural effusion and 1 had SLE. Pleural fluid and serum samples were taken at intervals 1 to 24 hours for determination of CMX levels. The following results were obtained: Intravenous drip infusion of 1 g CMX yielded a peak pleural concentration of 4.5 micrograms/ml after 2 hours and pleural levels over 3 micrograms/ml were maintained for 5.5 hours after intravenous drip administration. Ratio maximum pleural concentration to peak serum level reached 15.0 +/- 8.3% at 2 hours after intravenous drip administration.

摘要

对5例胸腔积液患者静脉滴注单剂量1g头孢甲肟(CMX)。研究组包括3名男性和2名女性,年龄38至69岁(平均54.8岁);4例为癌性胸腔积液,1例为系统性红斑狼疮(SLE)。在1至24小时内间隔采集胸水和血清样本以测定CMX水平。结果如下:静脉滴注1g CMX后2小时胸腔峰值浓度为4.5微克/毫升,静脉滴注后胸膜水平超过3微克/毫升维持5.5小时。静脉滴注后2小时胸腔最大浓度与血清峰值水平之比达到15.0±8.3%。

相似文献

1
[Penetration of cefmenoxime into pleural fluid].[头孢甲肟在胸腔积液中的渗透情况]
Jpn J Antibiot. 1984 Oct;37(10):1763-5.
2
[Prophylactic effects of cefmenoxime against postoperative infections after thoracotomy. Studies of cefmenoxime transfer from serum to pleural fluid and of clinical effects of cefmenoxime].[头孢甲肟对开胸术后感染的预防作用。头孢甲肟从血清向胸液转移的研究及头孢甲肟的临床效果]
Jpn J Antibiot. 1987 Feb;40(2):295-302.
3
[Cefmenoxime concentrations in human blood, bile and gallbladder in administration before surgery].
Jpn J Antibiot. 1985 Aug;38(8):2119-23.
4
[Clinical study of cefmenoxime in thoracic surgery. Transfer of cefmenoxime to lung tissue and pleural fluid and prophylaxis of postoperative infections].
Jpn J Antibiot. 1987 Sep;40(9):1628-38.
5
[Transfer of cefmenoxime to burn blister fluids].头孢甲肟向烧伤水疱液中的转移
Jpn J Antibiot. 1984 Mar;37(3):295-302.
6
[Study on the prostatic tissue levels of cefmenoxime (CMX)].[头孢甲肟(CMX)前列腺组织水平的研究]
Hinyokika Kiyo. 1985 Feb;31(2):273-9.
7
[Clinical study on cefmenoxime (CMX) in urology].[头孢甲肟(CMX)在泌尿外科的临床研究]
Hinyokika Kiyo. 1983 Jan;29(1):95-103.
8
[The concentration of cefmenoxime after intravenous drip infusion in digestive organs and exudates from abdominal and thoracic cavities in human].[人静脉滴注头孢甲肟后在消化器官及胸腹腔渗出液中的浓度]
Jpn J Antibiot. 1985 Jun;38(6):1643-7.
9
[Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration].
Jpn J Antibiot. 1983 Jul;36(7):1604-14.
10
[Basic studies of cefmenoxime].[头孢甲肟的基础研究]
Jpn J Antibiot. 1984 Mar;37(3):290-4.

引用本文的文献

1
Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢甲肟。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1987 Aug;34(2):188-221. doi: 10.2165/00003495-198734020-00002.